CVS’s stock impacted as Medicare Advantage issues weigh on results
May 2, 2024- Shares of CVS Health Corp suffered the biggest drop in 15 years, according to MarketWatch, after the pharmacy/healthcare-services company missed first quarter…
JHC’s Dail-eNews
Hospitals no longer required to report COVID-19 data to CDC
May 2, 2024- COVID-19 data reporting requirements, including COVID-19 admissions, ICU capacity, and other related statistics for hospitals have recently changed. The Department for Health…
Blickman Industries welcomes Linda Waltheras Chief Strategy Officer
May 1, 2024- Blickman Industries is proud to announce the hire of industry veteran, Linda Walther, for a newly created position of Chief Strategy Officer….
Value-based care: An evolution, not a revolution
May 1, 2024- Value-based care – the concept of delivering coordinated care that enables better patient outcomes and better experiences at a reduced cost –…
Henry Schein to present at Investor Conferences in May 2024
May 1, 2024- Henry Schein, Inc. announced that the Company will present at the following investor conferences in May including The Bank of America Healthcare…
ArchWell Health and Helping Hands of Vegas Valley partner to address needs of seniors
May 1, 2024- ArchWell Health announced its partnership with Helping Hands of Vegas Valley (HHOVV) to address lifestyle barriers to better health for seniors in…
A distribution perspective on advocating for clinical laboratories amid transformation
May 1, 2024- To advocate for the value of distribution in the healthcare ecosystem, the Health Industry Distributors Association (HIDA) regularly meets and holds annual…
Guidance released for navigating supply chain disruptions caused by faulty syringes from China
May 1, 2024- ECRI, a global safety nonprofit, has shared recommendations about mitigating the threats posed by malfunctioning syringes manufactured in China. In an ECRI Exclusive…
Humana Healthy Horizons commits to improving health of Louisianians
April 30, 2024- Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana, Inc. announced that it will invest this year in support…
U.S. FDA approves Pfizer’s BEQVEZ™, a one-time gene therapy for adults with hemophilia B
April 30, 2024- Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with…